Search
Search Results
- Publication:
- Oakland, Calif. : California HealthCare Foundation, c2005
- Subject(s):
- Chronic Disease
Patient Care Management -- methods
Telephone
Communication
Cost-Benefit Analysis
Counseling
Patient Education as Topic
Process Assessment (Health Care)
Program Evaluation
Social Support
Telephone -- statistics & numerical data
Humans
United States
- Publication:
- Oakland, Calif. : California HealthCare Foundation, [2009]
- Subject(s):
- Comparative Effectiveness Research
Cost-Benefit Analysis
Decision Making
Insurance Coverage
Insurance, Health -- economics
Leadership
Medicare
Outcome Assessment (Health Care)
Public Opinion
Humans
California
- Author(s):
- Weiner, Janet, author
Linas, Benjamin, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, September 2018
- Subject(s):
- Cost-Benefit Analysis
Hepatitis C -- diagnosis
Mass Screening -- economics
Eligibility Determination
Health Policy
Hepatitis C -- drug therapy
Insurance Coverage -- economics
Mass Screening -- trends
Medicaid -- economics
Sofosbuvir -- economics
Sofosbuvir -- therapeutic use
Practice Guidelines as Topic
Humans
United States
Centers for Disease Control and Prevention (U.S.)
- Author(s):
- Lindrooth, Richard C., author
Yakusheva, Olga, author
Fairman, Julie, author
Weiner, Janet, author
Naylor, Mary D., author
Pauly, Mark V., author
- Publication:
- [Philadelphia, Penna.] : Leonard Davis Institute of Health Economics, October 2015
- Subject(s):
- Cost-Benefit Analysis
Economics, Nursing
Health Care Costs
Nursing Staff, Hospital -- economics
Outcome Assessment (Health Care)
Quality of Health Care -- economics
Education, Nursing, Baccalaureate -- economics
Medicare -- economics
Nurses
Nurse's Role
Nursing Staff, Hospital -- education
Personnel Staffing and Scheduling
Reimbursement Mechanisms -- economics
Humans
United States
United States.
- Author(s):
- Yakusheva, Olga, author
Lindrooth, Richard C., author
Weiner, Janet, author
Spetz, Joanne, author
Pauly, Mark V., author
- Publication:
- [Philadelphia, Pennsylvania] : Leonard Davis Institute of Health Economics, November 2015
- Subject(s):
- Cost-Benefit Analysis
Medicare -- economics
Nurses
Nurse's Role
Nursing Staff, Hospital -- economics
Outcome Assessment (Health Care)
Cross Infection -- economics
Health Care Costs
Health Care Reform -- legislation & jurisprudence
Patient Readmission -- economics
Patient Readmission -- legislation & jurisprudence
Quality Indicators, Health Care
Quality of Health Care
Reimbursement, Incentive
Value-Based Purchasing
Humans
United States
United States.
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017
- Subject(s):
- Arthritis, Rheumatoid -- drug therapy
Arthritis, Rheumatoid -- immunology
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Drug Therapy, Combination
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Janus Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Tumor Necrosis Factors -- antagonists & inhibitors
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
- Subject(s):
- Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic -- drug therapy
Interleukin-4 Receptor alpha Subunit -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors -- therapeutic use
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Cyclosporine -- therapeutic use
Phosphodiesterase 4 Inhibitors -- adverse effects
Phototherapy
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
- Subject(s):
- Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States
- Publication:
- Chestnut Hill, MA : Center for Retirement Research at Boston College, [2008]
- Subject(s):
- Consumer Behavior
Health Benefit Plans, Employee -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Aged
Cost-Benefit Analysis
Employer Health Costs -- statistics & numerical data
Health Benefit Plans, Employee -- economics
Income
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
